HK1025251A1 - Use of gastrointestinal lipase inhibitors - Google Patents

Use of gastrointestinal lipase inhibitors

Info

Publication number
HK1025251A1
HK1025251A1 HK00104500A HK00104500A HK1025251A1 HK 1025251 A1 HK1025251 A1 HK 1025251A1 HK 00104500 A HK00104500 A HK 00104500A HK 00104500 A HK00104500 A HK 00104500A HK 1025251 A1 HK1025251 A1 HK 1025251A1
Authority
HK
Hong Kong
Prior art keywords
lipase inhibitors
gastrointestinal lipase
gastrointestinal
inhibitors
lipase
Prior art date
Application number
HK00104500A
Other languages
English (en)
Inventor
Jonathan Brian Hauptman
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21894047&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1025251(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of HK1025251A1 publication Critical patent/HK1025251A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Plant Substances (AREA)
HK00104500A 1997-02-05 2000-07-21 Use of gastrointestinal lipase inhibitors HK1025251A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3738397P 1997-02-05 1997-02-05
PCT/EP1998/000468 WO1998034630A1 (fr) 1997-02-05 1998-01-29 Utilisation d'inhibiteurs des lipases gastro-intestinales

Publications (1)

Publication Number Publication Date
HK1025251A1 true HK1025251A1 (en) 2000-11-10

Family

ID=21894047

Family Applications (1)

Application Number Title Priority Date Filing Date
HK00104500A HK1025251A1 (en) 1997-02-05 2000-07-21 Use of gastrointestinal lipase inhibitors

Country Status (28)

Country Link
US (1) US6147108A (fr)
EP (1) EP1017408B1 (fr)
JP (1) JP2001509173A (fr)
KR (1) KR100479968B1 (fr)
CN (1) CN1154505C (fr)
AR (1) AR011106A1 (fr)
AT (1) ATE292975T1 (fr)
AU (1) AU740375B2 (fr)
BR (1) BR9807655A (fr)
CA (1) CA2278854C (fr)
CZ (1) CZ295567B6 (fr)
DE (1) DE69829763T2 (fr)
DK (1) DK1017408T3 (fr)
ES (1) ES2239799T3 (fr)
HK (1) HK1025251A1 (fr)
HU (1) HU230834B1 (fr)
ID (1) ID22650A (fr)
IL (1) IL131007A0 (fr)
ME (1) ME00578A (fr)
NO (1) NO324452B1 (fr)
NZ (1) NZ336755A (fr)
PL (1) PL191222B1 (fr)
PT (1) PT1017408E (fr)
RU (1) RU2201272C2 (fr)
TR (1) TR199901853T2 (fr)
WO (1) WO1998034630A1 (fr)
YU (1) YU34199A (fr)
ZA (1) ZA98753B (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100479968B1 (ko) * 1997-02-05 2005-03-30 에프. 호프만-라 로슈 아게 위장 리파아제 억제제의 용도
AR025587A1 (es) * 1999-09-13 2002-12-04 Hoffmann La Roche Formulaciones en dispersion que contienen inhibidores de lipasa
AR025609A1 (es) 1999-09-13 2002-12-04 Hoffmann La Roche Formulaciones lipidas solidas
EP1134231B1 (fr) 2000-03-14 2009-04-15 Unilever N.V. Domaines variables de la chaine lourde d'anticorps contre des lipases humaines alimentaires et leurs utilisations
US6828297B2 (en) * 2001-06-04 2004-12-07 Nobex Corporation Mixtures of insulin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
US7053080B2 (en) * 2001-09-21 2006-05-30 Schering Corporation Methods and therapeutic combinations for the treatment of obesity using sterol absorption inhibitors
US9174176B2 (en) * 2003-01-09 2015-11-03 Disperse Systems, Inc. Ultrasonic dispersion apparatus, system, and method
US7510849B2 (en) * 2004-01-29 2009-03-31 Glucolight Corporation OCT based method for diagnosis and therapy
CN105801686B (zh) 2004-07-19 2020-04-07 比奥孔有限公司 胰岛素-低聚物共轭物、制剂及其用途
US8036727B2 (en) 2004-08-11 2011-10-11 Glt Acquisition Corp. Methods for noninvasively measuring analyte levels in a subject
US7822452B2 (en) 2004-08-11 2010-10-26 Glt Acquisition Corp. Method for data reduction and calibration of an OCT-based blood glucose monitor
US7254429B2 (en) 2004-08-11 2007-08-07 Glucolight Corporation Method and apparatus for monitoring glucose levels in a biological tissue
US8217025B2 (en) * 2006-11-17 2012-07-10 Harbor Therapeutics, Inc. Drug screening and treatment methods
ATE477820T1 (de) * 2007-09-12 2010-09-15 Mader S R L Pharmazeutische zusammensetzungen zur oralen verabreichung bei der behandlung von adipositas- patienten
MX2010004072A (es) * 2007-10-15 2010-09-14 Inventis Dds Pvt Ltd Composicion farmaceutica de orlistat.
EP2203181B1 (fr) 2007-10-16 2018-02-14 Biocon Limited Composition pharmaceutique solide administrable par voie orale et procédé associé
US8571617B2 (en) 2008-03-04 2013-10-29 Glt Acquisition Corp. Flowometry in optical coherence tomography for analyte level estimation
WO2010042499A1 (fr) * 2008-10-06 2010-04-15 Banner Pharmacaps, Inc. Solutions stables d'orlistat pour formes galéniques pharmaceutiques
FR3017536B1 (fr) * 2014-02-18 2017-05-26 Univ La Rochelle Compositions pour la prevention et/ou le traitement de pathologies liees a l'alpha-glucosidase
EP3429567B1 (fr) 2016-03-16 2024-01-10 The J. David Gladstone Institutes Procédés et compositions pour traiter l'obésité et/ou le diabète et pour identifier des agents de traitement candidats
WO2019018849A1 (fr) * 2017-07-21 2019-01-24 Kieu Hoang Statines (atorvastatine) pouvant abaisser le taux de glycémie chez un diabétique

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1247547A (fr) * 1983-06-22 1988-12-28 Paul Hadvary Derives de leucine
CA1270837A (fr) * 1984-12-21 1990-06-26 Hoffmann-La Roche Limited Oxetanones
CA1328881C (fr) * 1984-12-21 1994-04-26 Pierre Barbier Procede pour la fabrication d'oxetanones
CA2035972C (fr) * 1990-02-23 2006-07-11 Martin Karpf Procede de preparation d'oxetanones
US5298497A (en) * 1990-05-15 1994-03-29 E. R. Squibb & Sons, Inc. Method for preventing onset of hypertension employing a cholesterol lowering drug
US5190970A (en) * 1990-10-19 1993-03-02 E. R. Squibb & Sons, Inc. Method for preventing onset of or treating Type II diabetes employing a cholesterol lowering drug alone or in combination with an ace inhibitor
US5130333A (en) * 1990-10-19 1992-07-14 E. R. Squibb & Sons, Inc. Method for treating type II diabetes employing a cholesterol lowering drug
US5345056A (en) * 1991-12-12 1994-09-06 Motorola, Inc. Plasma based soldering by indirect heating
CA2098167C (fr) * 1992-06-24 2006-12-19 Dorothea Isler Aliments pour humains et animaux contenant un inhibiteur de la lipase
CA2128044C (fr) * 1993-08-05 2007-02-20 Klaus-Dieter Bremer Compositions pharmaceutiques comportant un glucosidase et/ou un inhibiteur d'amylase, et un inhibiteur des lipases
JP3532999B2 (ja) * 1995-03-24 2004-05-31 株式会社ロッテ 新規なタンニン類およびこれを有効成分とするリパーゼ阻害剤
JPH09227398A (ja) * 1996-02-20 1997-09-02 Zeria Pharmaceut Co Ltd 抗肥満剤
KR100479968B1 (ko) * 1997-02-05 2005-03-30 에프. 호프만-라 로슈 아게 위장 리파아제 억제제의 용도
US6004996A (en) * 1997-02-05 1999-12-21 Hoffman-La Roche Inc. Tetrahydrolipstatin containing compositions

Also Published As

Publication number Publication date
ME00578A (en) 2011-12-20
AU740375B2 (en) 2001-11-01
JP2001509173A (ja) 2001-07-10
ZA98753B (en) 1998-08-05
ES2239799T3 (es) 2005-10-01
DK1017408T3 (da) 2005-08-01
HUP0001014A3 (en) 2000-12-28
NO993717D0 (no) 1999-07-30
PL334975A1 (en) 2000-03-27
EP1017408A1 (fr) 2000-07-12
ATE292975T1 (de) 2005-04-15
PL191222B1 (pl) 2006-03-31
NZ336755A (en) 2001-06-29
YU34199A (sh) 2002-08-12
PT1017408E (pt) 2005-07-29
AU6616998A (en) 1998-08-26
KR100479968B1 (ko) 2005-03-30
CA2278854A1 (fr) 1998-08-13
AR011106A1 (es) 2000-08-02
DE69829763T2 (de) 2006-04-13
CZ295567B6 (cs) 2005-08-17
HUP0001014A2 (hu) 2000-08-28
WO1998034630A1 (fr) 1998-08-13
TR199901853T2 (xx) 1999-12-21
DE69829763D1 (de) 2005-05-19
NO324452B1 (no) 2007-10-22
EP1017408B1 (fr) 2005-04-13
KR20000070733A (ko) 2000-11-25
HU230834B1 (hu) 2018-07-30
CZ265199A3 (cs) 2000-02-16
RU2201272C2 (ru) 2003-03-27
IL131007A0 (en) 2001-01-28
ID22650A (id) 1999-12-02
NO993717L (no) 1999-10-04
CN1154505C (zh) 2004-06-23
CA2278854C (fr) 2014-03-04
US6147108A (en) 2000-11-14
CN1246798A (zh) 2000-03-08
BR9807655A (pt) 2000-02-15

Similar Documents

Publication Publication Date Title
PL334846A1 (en) Sulphamidic inhibitors of metaloproteases
HK1025251A1 (en) Use of gastrointestinal lipase inhibitors
PL343007A1 (en) Inhibitors of phospholipase enzymes
IL137718A0 (en) Inhibitors of phospholipase enzymes
PL341762A1 (en) Precursors of aspartil protease inhibitors
EP1009415A4 (fr) INHIBITEURS DE $g(b)-LACTAMASES ET LEURS UTILISATIONS
PL339738A1 (en) Novel lactamic inhibitors of metaloproteinases
ZA98376B (en) Sulfamide-metalloprotease inhibitors
PL331856A1 (en) Heterocyclic inhibitors of metaloprotease
PL327569A1 (en) Promedications of thrombosin inhibitors
AP9701054A0 (en) Inhibitors of cycteine protease
HU0900792D0 (en) Use of renin-angiotensin inhibitors
PL337725A1 (en) Inhibitors of proteases
PL328665A1 (en) Inhibitors of serinic protease
ZA983065B (en) Inhibitors of protein farnesyltranferase
GB2346885B (en) Phospholipase inhibitor
PL328081A1 (en) Peptidic inhibitors of haematoblast proliferation
AU1212002A (en) Use of lipase inhibitors
GB9700233D0 (en) Use of glycosidase inhibitors
GB9713139D0 (en) Use of enzymes
EP0904069A4 (fr) Inhibiteurs pla2 de l'angiogenese
GB9703335D0 (en) Inhibitors
GB9727371D0 (en) Inhibitors
GB9725783D0 (en) Inhibitors
GB9713709D0 (en) Inhibitors

Legal Events

Date Code Title Description
PF Patent in force
PE Patent expired

Effective date: 20180128